MicroRNA signatures differentiate uterine cancer tumor subtypes
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 118 (3), 251-257
- https://doi.org/10.1016/j.ygyno.2010.05.010
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemiaNature Cell Biology, 2010
- miR-19 is a key oncogenic component of mir-17-92Genes & Development, 2009
- Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factorProceedings of the National Academy of Sciences, 2009
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancerProceedings of the National Academy of Sciences, 2008
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Genes & Development, 2008
- MicroRNA expression profiles of esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2008
- Widespread deregulation of microRNA expression in human prostate cancerOncogene, 2007
- miRNA Profiling for Diagnosis and Prognosis of Human CancerDNA and Cell Biology, 2007
- MicroRNA expression profiles classify human cancersNature, 2005
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002